1. Introduction {#sec1-molecules-23-01652}
===============

*Dryopteris fragrans* (L.) Schott ([Figure 1](#molecules-23-01652-f001){ref-type="fig"}) belonging to the genus Dryopteris is a perennial herb with aroma widely distributed throughout the world and is mostly distributed in the alpine and volcanic regions of Northeast China \[[@B1-molecules-23-01652],[@B2-molecules-23-01652]\]. *D. fragrans* has been used as folk medicine for treating arthritis and skin diseases such as psoriasis, dermatophytosis, and more \[[@B3-molecules-23-01652]\]. Previous phytochemical investigations on this plant have led to the identification of terpenoids \[[@B4-molecules-23-01652]\], phloroglucinols \[[@B5-molecules-23-01652]\], glucosides \[[@B6-molecules-23-01652]\], and other phenolic derivatives such as coumarin \[[@B3-molecules-23-01652]\]. The earlier biological studies have shown that *D. fragrans* was a valuable medicinal plant resource with extensive biological activities including anti-cancer, anti-oxidation, insect repellent, anti-microbial, and anti-inflammation activities \[[@B3-molecules-23-01652],[@B4-molecules-23-01652],[@B5-molecules-23-01652],[@B6-molecules-23-01652],[@B7-molecules-23-01652]\].

Of its various biological effects, the mechanism of anti-cancer effects has been studied most. Dryofragin, which is a derivative of phloroglucinol, was found to activate the endogenous pathway of apoptosis by affecting the changes of ROS in mitochondria and inducing changes in mitochondria in breast cancer cell MCF-7 and to cause tumor cell apoptosis by the apoptosis-related protein Bcl-2, Bax, Caspase-9, Caspase-3, and PARP \[[@B8-molecules-23-01652]\]. It has also been reported to be an inhibitor of migration and invasion of the human osteosarcoma cell line U2OS through the PI3K/Akt and MAPK energy pathway involving MMP-2/9 and TIMP-1/2 proteins \[[@B9-molecules-23-01652]\]. Aspidin PB, which is another phloroglucinol derivative from *D. fragrans*, has been recorded as a tumor cell-inhibiting agent for its impact on cyclin p53/p21 and mitochondrial changes in human osteosarcoma cells Saos-2, U2OS, and HOS \[[@B10-molecules-23-01652]\]. In addition, there have been many other reports on compounds from *D. fragrans* with cytotoxicity \[[@B11-molecules-23-01652],[@B12-molecules-23-01652],[@B13-molecules-23-01652]\]. To further study cytotoxic constituents from *D. fragrans*, a cytotoxicity-guided isolation of the extract of *D. fragrans* was designed. The isolation of two new phenolic derivatives and six known compounds by cytotoxicity-guided tracking as well as their cytotoxicity and immunomodulatory activity detection is described in this paper.

2. Results and Discussion {#sec2-molecules-23-01652}
=========================

2.1. Determination of Isolated Compounds {#sec2dot1-molecules-23-01652}
----------------------------------------

After two round cytotoxicity screening by MTT \[[@B14-molecules-23-01652]\] and CCK-8 \[[@B15-molecules-23-01652]\] assay, Fractions SG1‒SG7 from the petroleum ether-soluble part with prominent cytotoxic activities were selected as the bioactive sites ([Figures S1 and S2](#app1-molecules-23-01652){ref-type="app"}). Two new phenolic derivatives known as dryofragone (**1**) and dryofracoumarin B (**2**) ([Figure 2](#molecules-23-01652-f002){ref-type="fig"}) along with six known compounds (**3**--**8**) ([Figure 2](#molecules-23-01652-f002){ref-type="fig"}), were isolated from the above seven bioactive fractions by using extensive chromatographic methods like silica gel, MCI gel, Sephadex LH-20, and HPLC. The known compounds were identified as dryofracoumarin A (**3**) \[[@B3-molecules-23-01652]\], vitamin E quinone (**4**) \[[@B16-molecules-23-01652]\], albicanol (**5**) \[[@B5-molecules-23-01652]\], 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone (**6**) \[[@B17-molecules-23-01652]\], norflavesone (**7**) \[[@B18-molecules-23-01652]\], and aspidinol (**8**) \[[@B19-molecules-23-01652]\] by comparing their ^1^H- and ^13^C-NMR data with that reported in the literature.

Compound **1** was obtained as yellow powder from CHCl~3~. The HR-ESI-MS data (*m*/*z* 239.0926 \[M − H\]^−^, calcd for 239.0925) of **1** showed the molecular formula C~12~H~16~O~5~, which correspond to five degrees of unsaturation. The IR spectrum of **1** displayed hydroxyls (3321 cm^−1^), carbonyl groups (1714 cm^−1^), and double bonds (1607 cm^−1^) absorptions. The red shifted hydroxyl signal (3321 cm^−1^) also showed that some hydroxyls in **1** were involved in the hydrogen bonding interaction. The ^1^H-NMR spectrum of **1** ([Table 1](#molecules-23-01652-t001){ref-type="table"}) showed one 3H-singlet at *δ*~H~ 1.54 for a tertiary methyl group, one 3H-singlet at *δ*~H~ 3.91 for a methoxy group, one 3H-triplet at *δ*~H~ 1.01 for a primary methyl group, and an olefinic proton at *δ*~H~ 5.37. The ^13^C-NMR spectrum of **1** revealed 12 resonance signals including two ketone carbons at *δ*~C~ 196.3 (conjugated) and 203.7, two pair of olefinic carbons (*δ*~C~ 189.4, 176.0, 104.5 and 94.5) with two oxygenated sites (*δ*~C~ 189.4 and 176.0), an oxygenated tertiary carbon (*δ*~C~ 75.4), a methoxy carbon (*δ*~C~ 57.4), two aliphatic methylene carbon (*δ*~C~ 41.0 and 18.7), and two methyl carbons (*δ*~C~ 30.2 and 14.1). The above evidence indicated that compound **1** presumably possessed an oxygenated phloroglucinol core \[[@B20-molecules-23-01652]\]. This inference was further confirmed by the 2D-NMR spectra ([Figure 3](#molecules-23-01652-f003){ref-type="fig"}). The long-range HMBC couplings---H-4/C-2, C-3, C-5, and C-6 as well as Me-11/C-1, C-2, and C-3 demonstrated the presence of a cyclohexadiene moiety with two oxygen-bearing carbon at C-2 and C-5. The HMBC correlation from a methoxy at *δ*~H~ 3.91 (Me-12) to a quaternary olefinic carbon at *δ*~C~ 176.0 (C-3) revealed that a methoxy was located at C-3. Furthermore, a butyryl was linked to C-6, which was supported by the HMBC correlations from protons at C-8 (*δ*~H~ 2.99 and 2.92) to carbons at *δ*~C~ 104.5 (C-6), 203.7 (C-7), 18.7 (C-9), and 14.1 (C-10), respectively. The CD experiment towards compound **1** was performed. However, the CD spectrum ([Figure S9](#app1-molecules-23-01652){ref-type="app"}) of **1** showed no characteristic cotton effect. Compound **1** was considered to be a pair of enantiomers.

Therefore, the structure of **1** was concluded to be a new acylphloroglucinol, 6-isobutyryl-2,5-dihydroxy-2-methyl-3-methoxy-cyclohexa-3,5-dien-1-one, and was named dryofragone.

Compound **2** was obtained as a mixture with compound **3** initially. The ^13^C-NMR spectrum of the mixture revealed 28 resonance signals ([Figure S12](#app1-molecules-23-01652){ref-type="app"}) in which half were consistent with the data reported for a coumarin and dryofracoumarin A (**3**) \[[@B3-molecules-23-01652]\]. However, the ESI-MS data (*m*/*z* 249\[M + H\]^+^, 271\[M + Na\]^+^, 287\[M + K\]^+^) of the mixture showed only one molecular weight (248 Da), which aligned with that of **3**. Consequently, the other half of carbon resonance signals in the ^13^C-NMR for the mixture, which were highly similar with that of **3**, were supposed to be of an isomer of **3** featuring exchanged positions of hydroxyl and methoxy groups in the coumarin core. Based on the large space size of tert-butyl dimethyl silicyl group, which can strike the balance of molecular polarity for compounds **2** and **3** and the high yield of the desilication step, a silicon etherification-desilication procedure was designed for the isolation of the mixture (See [Section 3.5](#sec3dot5-molecules-23-01652){ref-type="sec"} and [Figure 4](#molecules-23-01652-f004){ref-type="fig"}). NMR data of compounds **2** and **3** are shown in [Table 2](#molecules-23-01652-t002){ref-type="table"}. After the chemical derivatization, compound **2** was afforded as a simplex. The IR spectrum of **2** exhibited a signal of hydroxyl with no hydrogen bonds (3548 cm^−1^), a strong band at 1668 cm^−1^ for the lactone subunit in coumarin core, and absorptions (1636, 1602, 1572 cm^−1^) of benzene ring moiety in coumarin. The HR-ESI-MS data (*m*/*z* 247.0975 \[M − H\]^−^, calcd for 247.0976) indicated a molecular formula C~14~H~16~O~4~ with seven degrees of unsaturation for **2**. The HMBC correlations ([Figure 3](#molecules-23-01652-f003){ref-type="fig"}) from Me-12 and -13 (*δ*~H~ 1.30 × 2) to C-4 (*δ*~C~ 163.0) as well as the correlations from H-11(*δ*~H~ 3.25) to C-3 (*δ*~C~ 107.8), C-4 (*δ*~C~ 163.0), and C-9 (*δ*~C~ 112.2), which suggests that an isopropyl was fused to C-4. Another HMBC correlation Me-15/C-8 verified that a methoxyl group was linked to C-8. In addition, the HMBC correlations from an isolated methyl (*δ*~H~ 2.31) to C-5 (*δ*~C~ 120.0), C-6 (*δ*~C~ 121.1), and C-7 (*δ*~C~ 150.0) inferred a methyl at C-6 in **2**. The above analyses disclosed our former hypothesis. As a result, the structure of **2** was determined to be 7-hydroxy-6-methyl-8-methoxy-4-isopropyl-2H-chromen-2-one, which was given the trivial name of dryofracoumarin B.

2.2. In Vitro Cytotoxicity and Immunomodulatory Activity Detection {#sec2dot2-molecules-23-01652}
------------------------------------------------------------------

For all the isolates, their cytotoxicities against nine human cancer cell lines known as HepG2, A549, HeLa, U251, HOS, MG63, U2OS, MB231, and SKBR-3 as well as their immuno-regulation activities were evaluated. The cytotoxicities were screened using the CCK-8 assay \[[@B15-molecules-23-01652]\]. The IC~50~ values of cytotoxicities for the eight compounds are shown in [Table 3](#molecules-23-01652-t003){ref-type="table"}. For compounds isolated by cytotoxicity-guided tracking, they exhibited moderate activities to the HeLa cell line and weak activities to glioma, liver cancer, and lung cancer cell lines. However, they were not very sensitive to osteosarcoma and breast cancer cell lines when compared to the crude extract. For their immuno-regulation activities, LPS stimulated THP-1 cells were used as the in vitro model for the detection \[[@B21-molecules-23-01652]\]. Fenofibrate (Feno) pre-treatment (20 μM) was used as a positive control \[[@B21-molecules-23-01652]\]. The results for immuno-regulation activities are shown in [Figure 5](#molecules-23-01652-f005){ref-type="fig"}. Only compounds **4** and **5** could enhance the secretion of the factors *TNF-α* and *IL-1β*. The results showed that compounds **4** and **5** may activate the LPS signaling pathway, which may modulate immunity to affect the growth of tumor cells.

3. Materials and Methods {#sec3-molecules-23-01652}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-23-01652}
------------------------------------

Optical rotations were recorded in MeOH using a JASCO P-1020 Polarimeter (Jasco Corp., Tokyo, Japan). UV spectra were acquired in MeOH with a Shimadzu UV-2401PC UV-VIS spectrophotometer (Shimadzu Corp., Kyoto, Japan). IR spectra were measured on a Bruker Tensor 27 FTIR Spectrometer with KBr disks (Bruker Corp., Karlsruhe, Germany). ^1^H-NMR, ^13^C-NMR, and 2D NMR spectra were recorded in CDCl~3~ using a Bruker AVANCE III-600 spectrometer or a Bruker DRX-400 spectrometer (Bruker Corp., St. Gallen, Switzerland). TMS was used as the internal standard. ESI-MS spectra were recorded using a Waters Xevo TQ-S Ultra High Pressure Liquid Chromatography Triple Quadrupole Mass Spectrometer (Waters Corp., Manchester, UK). HR-ESI-MS data were obtained using an Agilent G6230 Q-TOF mass instrument (Agilent Corp., Santa Clara, CA, USA). Column chromatography (CC) was performed using a silica gel (200--300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), MCI gel CHP 20P (75--150 µm, Mitsubishi Corp., Tokyo, Japan), and Sephadex LH-20 (25--100 mm, Pharmacia Biotech Ltd., Uppsala, Sweden). Thin-layer chromatography (TLC) was performed using pre-coated silica gel GF254 plates (0.25 mm in thickness for analysis and 0.60 mm thickness for preparation, Qingdao Marine Chemical Inc., Qingdao, China) with various solvent systems. Spots were visualized under UV light (254 nm) and colored by iodine and by spraying silica gel plates with 10% H~2~SO~4~ in MeOH followed by heating. Preparative HPLC separations were performed on a CXTH system equipped with a UV3000 detector (Beijing Chuangxintongheng Instruments Co. Ltd., Beijing, China), and a Kromasil C~18~ column (250 mm × 20 mm i.d., 5 mm, EKA Chemicals Corp., Bohus, Sweden) using a flow rate of 8.0 mL/min at a column temperature of 25 °C. Semi-preparative HPLC was conducted on a HITACHI Chromaster system (Hitachi Ltd., Tokyo, Japan) equipped with an Agilent ZORBAXSB-C~18~ column (150 mm × 9.4 mm i.d., 5 mm, Agilent Corp., Santa Clara, CA, USA) using a flow rate of 3.0 mL/min at a column temperature of 25 °C. The detection was performed with a DAD detector.

3.2. Plant Material {#sec3dot2-molecules-23-01652}
-------------------

The aerial parts of *Dryopteris fragrans* (L.) Schott were collected in June 2016 from the Wudalianchi scenic area, Heihe City, Helongjiang Province, China and identified by Prof. Baodong Liu from the Harbin Normal University. A voucher specimen (No. df-20070702-9) was deposited in the Plant Herbarium of Northeast Agricultural University in Harbin, China.

3.3. Determination of Anti-Tumor Fraction of Dryopteris fragrans {#sec3dot3-molecules-23-01652}
----------------------------------------------------------------

After methanol extraction, the crude extract was then partitioned with petroleum ether (rt), dichloromethane (DCM) (rt), EtOAc (rt), and n-BuOH (rt) in sequence. The crude extract was divided into six parts (the whole extracts, petroleum ether layer, DCM layer, EtOAc layer, n-BuOH layer, and water phase). Each fraction was dissolved in DMSO and the final concentration of DMSO in the cell culture medium was no more than 0.1%. The osteosarcoma cell lines HOS and MG63 were used as the first round screening target in MTT \[[@B14-molecules-23-01652]\] for the above six parts of the crude extracts. As shown in [Figure S1](#app1-molecules-23-01652){ref-type="app"}, petroleum ether fraction of crude extracts had the most obvious cytotoxic effects at the point of 48 h. The petroleum ether fraction was then divided into 14 sub-fractions (Fr SG1‒SG14) by using silica gel column chromatography. The above 14 fractions were then subjected to MTT or CCK-8 assay \[[@B15-molecules-23-01652]\] against HepG2, MB231, and MG63 cell lines, respectively. As shown in [Figure S2](#app1-molecules-23-01652){ref-type="app"}, Fractions SG1--SG7 from the petroleum ether-soluble part exhibited prominent cytotoxic activities.

3.4. Extraction and Isolation {#sec3dot4-molecules-23-01652}
-----------------------------

The air-dried aerial parts of *Dryopteris fragrans* (L.) Schott powder (2 kg) were extracted with 100% methanol (20 L × 2 d × 3) and ultrasonized (40 Hz) for 4 h at each time. After filtration, the filtrate was concentrated to yield the crude extract. The crude extract was then suspended in water (1.5 L) and partitioned with petroleum ether (3 × 1.5 L), DCM (3 × 1.5 L), EtOAc (3 × 1.5 L), and n-BuOH (3 × 1.5 L) sequentially. Guided by the first round cytotoxicity screening, the petroleum ether fraction (54 g) was chosen for further isolation. The petroleum ether-soluble part was then subjected to silica gel CC and eluted with petroleum ether--EtOAc (1:0--0:1) to create 14 fractions (SG1--SG14). According to the second round cytotoxicity screening, Fractions SG1--SG7 were selected as the isolation targets for the next step. Fractions SG1 and SG2 were not actually involved in the next step because their low polarities made an effective separation on column chromatography difficult.

Fraction SG3 (5.93 g) was submitted to the silica gel CC (petroleum ether--EtOAc 1:0--0:1) and Sephadex LH-20 CC (MeOH--CHCl~3~ 1:1) and followed by preparative TLC (petroleum ether--EtOAc 11:2, Rf = 0.53) to afford compound **4** (14.4 mg). Compound **5** (103.2 mg) was isolated from Fraction SG4 (5.01 g) by undergoing a protocol of repeated silica gel CC (petroleum ether--EtOAc 1:0--10:1), Sephadex LH-20 CC (MeOH--CHCl3 1:1), and preparative TLC (petroleum ether--EtOAc 8:1, Rf = 0.40). Fraction SG6 (3.54 g) was chromatographed on MCI CC (MeOH--H~2~O 40:60 to 100:0) to yield 16 sub-fractions (Fr M1--M16). Further purification of Fr. M6 by semi-preparative HPLC (MeOH: H~2~O 53:47) resulted in the isolation of compounds **6** (15.8 mg) and **7** (10.0 mg). Fraction SG7 (2.49 g) was further separated by MCI CC (MeOH--H~2~O 20:80 to 100:0) to yield 11 fractions (Fr. M~2~1--M~2~11). Compound **1** (4.5 mg) was purified from Fraction M~2~4 using semi-preparative HPLC (MeOH:H~2~O 58:42). In the same way, compound **8** (2.0 mg) was obtained from Fraction M~2~7. Compounds **2** and **3** were obtained as a mixture (17.0 mg) from Fraction M~2~6 by semi-preparative HPLC (MeOH:H~2~O 77:23). They were separated by a silicon etherification-desilication procedure (See [Section 3.5](#sec3dot5-molecules-23-01652){ref-type="sec"}).

Dryofragone (**1**): yellow powder (CHCl~3~). \[*α*$\rbrack_{D}^{23.7}$ --20.3 (*c* 0.10, MeOH); UV (MeOH) *λ*~max~ (log *ε*): 198 (3.17) nm, 241 (3.38) nm, 276 (3.20) nm, 320 (3.14) nm, IR (KBr) *ν*~max~ IR (KBr) *ν*~max~ 3321, 2929, 1714, 1607, 1533, 1442, 1231, 1104; ^1^H-NMR (600 MHz, CDCl~3~): *δ*~H~ 5.37 (1H, s, H-4), 3.91 (3H, s, Me-12), 2.99 (1H, m, H-8a), 2.92 (1H ,m, H-8b), 1.69 (2H, m, H-9), 1.54 (3H, s, Me-11), 1.01 (3H, t, *J* = 7.4 Hz, Me-10); 203.7 (C-7), 196.3 (C-1), 189.4 (C-5), 176.0 (C-3), 104.5 (C-6), 94.5 (C-4), 75.4 (C-2), 57.4 (C-12), 41.0 (C-8), 30.2 (C-11), 18.7 (C-9),14.1 (C-10), ESI-MS *m*/*z* 239 \[M − H\]^−^, and HR-ESI-MS *m*/*z* 239.0926 \[M − H\]^−^ (calcd for C~12~H~15~O~5~, 239.0925).

3.5. Silicon Etherification Involved Isolation of 2 and 3 {#sec3dot5-molecules-23-01652}
---------------------------------------------------------

### 3.5.1. Silicon Etherification of the Mixture of Compounds **2** and **3** {#sec3dot5dot1-molecules-23-01652}

With regard to the solution of the mixture of Compounds **2** and **3** (17 mg, 0.068 mmol) in dry DCM (0.5 mL), 2,6-luditine (30 μL, 0.27 mmol, 4.0 equiv) was added at 0 °C, which is followed by the addition of TBSOTf (35 μL, 0.17 mmol, 2.5 equiv). The resulting mixture was warmed to room temperature (rt) naturally, stirred for 6 h, and then quenched with water (2.0 mL). The mixture was then stirred for 10 min, followed by an extraction with EtOAc (10.0 mL) three times, and the EtOAc layer was dried over anhydrous Na~2~SO~4~ and subsequently concentrated. The residue was further purified by semi-preparative HPLC (85% MeOH in H~2~O, 3 mL/min, a HITACHI Chromaster system equipped with a DAD detector, an Agilent ZORBAX SB-C~18~ column, 150 mm × 9.4 mm i.d., 5 μm) to yield compound **2a** (6.8 mg, *t*~R~ = 19.8 min) and **3a** (4.2 mg, *t*~R~ = 15.8 min) as white solids. Compound **2a**: ^1^H-NMR (400 MHz, CDCl~3~): *δ*~H~ 7.17 (1H, s, H-5), 6.18 (1H, s, H-3), 3.91 (3H, s, Me-15), 3.24 (1H, m, H-11), 2.29 (3H, s, Me-14), 1.30 (6H, d, *J* = 6.8 Hz, Me-12, 13), 1.03 (9H, s, Me-19, 20, 21), 0.24 (6H, s, Me-16, 17), ^13^C-NMR (100 MHz, CDCl~3~): *δ*~C~ 162.5 (C-4), 161.7 (C-2), 150.1 (C-7), 146.9 (C-10), 138.3 (C-8), 126.5 (C-6), 119.5 (C-5), 113.4 (C-9), 108.5 (C-3), 61.1 (C-15), 28.7 (C-11), 26.1 × 3 (C-19, 20, 21), 22.1 × 2 (C-12, 13), 19.0 (C-18), 17.7 (C-14), −4.0 × 2 (C-16, 17). Compound **3a**: ^1^H-NMR (400 MHz, CDCl~3~): *δ*~H~ 7.07 (1H, s, H-5), 6.21 (1H, s, H-3), 3.82 (3H, s, Me-15), 3.24 (1H, m, H-11), 2.32 (3H, s, Me-14), 1.30 (6H, d, *J* = 6.8 Hz, Me-12, 13), 1.08 (9H, s, Me-19, 20, 21), 0.25 (6H, s, Me-16, 17), ^13^C-NMR (100 MHz, CDCl~3~): *δ*~C~ 162.2 (C-4), 161.4 (C-2), 152.5 (C-7), 145.3 (C-10), 137.2 (C-8), 127.8 (C-6), 117.0 (C-5), 115.4 (C-9), 109.8 (C-3), 60.2 (C-15), 28.7 (C-11), 25.9 × 3 (C-19, 20, 21), 22.1 × 2 (C-12, 13), 18.8 (C-18), 16.4 (C-14), −4.2 × 2 (C-16, 17).

### 3.5.2. Desilication of Compound **2a** {#sec3dot5dot2-molecules-23-01652}

To a solution of compound **2a** (6.8 mg, 0.0188 mmol) in dry THF (0.1 mL), TBAF (1 M in THF, 19 μL, 0.0197 mmol, 1.05 equiv) was added at 0 °C. The resulting mixture was stirred at 0 °C for 5 min and then quenched by adding 1.0 mL of the saturated ammonium chloride aqueous solution. The resulting mixture was then extracted by EtOAc (5.0 mL) three times and the combined organic extracts were dried over anhydrous Na~2~SO~4~ and were then concentrated. The residue was purified by using flash column chromatography on the silica gel (200--300 mush, 1.0 × 3.0 cm, petroleum ether/EtOAc 4:1), which yielded compound **2** (4.5 mg, 96.6% yield) as a white solid. Compound **2**: UV (MeOH) *λ*~max~ (log *ε*): 206 (3.81) nm, 218 (3.52) nm, 250 (2.78) nm, 330 (3.29) nm; IR (KBr) *ν*~max~ 3548, 3466, 3169, 2942, 1668, 1602, 1460, 1404, 1229, 1094, 1024, 925, 856; ^1^H-NMR (600 MHz, CDCl~3~): *δ*~H~ 7.17 (1H, s, H-5), 6.16 (1H, s, H-3), 4.08 (3H, s, Me-15), 3.25 (1H, m, H-11), 2.31 (3H, s, Me-14), 1.30 (3H, d, *J* = 6.8 Hz, Me-12), 1.30 (3H, d, *J* = 6.8 Hz, Me-13); ^13^C-NMR (150 MHz, CDCl~3~): *δ*~C~ 163.0 (C-4), 161.5 (C-2), 150.0 (C-7), 145.5 (C-10), 133.6 (C-8), 121.1 (C-6), 120.0 (C-5), 112.2 (C-9), 107.8 (C-3), 61.9 (C-15), 28.7 (C-11), 22.1 (C-12), 22.1 (C-13), 15.9 (C-14), HR-ESI-MS: *m*/*z* 247.0975\[M − H\]^−^, calcd. 247.0976 for C~14~H~15~O~4~.

### 3.5.3. Desilication of Compound **3a** {#sec3dot5dot3-molecules-23-01652}

To a solution of compound **3a** (4.2 mg, 0.0116 mmol) in dry THF (0.1 mL), TBAF (1 M in THF, 12 μL, 0.0121 mmol, 1.05 equiv) was added at 0 °C. The resulting mixture was stirred at 0 °C for 5 min and then quenched by adding 1.0 mL of saturated ammonium chloride aqueous solution. The resulting mixture was then extracted by EtOAc (5.0 mL) three times and the combined organic extracts were dried over anhydrous Na~2~SO~4~ and concentrated. The residue was purified by flash column chromatography on the silica gel (200--300 mush, 1.0 × 3.0 cm, petroleum ether/EtOAc 4:1), which yielded compound **3** (2.8 mg, 97.4% yield) as a white solid. Compound **3**: ^1^H-NMR (600 MHz, CDCl~3~): *δ*~H~ 7.01 (1H, s, H-5), 6.22 (1H, s, H-3), 3.95 (3H, s, Me-15), 3.25 (1H, m, H-11), 2.32 (3H, s, Me-14), 1.31 (6H, d, *J* = 6.8 Hz, Me-12, 13); ^13^C-NMR (150 MHz, CDCl~3~): *δ*~C~ 163.0 (C-4), 161.1 (C-2), 147.8 (C-7), 141.3 (C-10), 136.7 (C-8), 127.5 (C-6), 115.5 (C-5), 114.5 (C-9), 109.2 (C-3), 60.5 (C-15), 28.7 (C-11), 21.9 (C-12 & C-13), and 16.3 (C-14).

3.6. MTT and CCK-8 Assay {#sec3dot6-molecules-23-01652}
------------------------

Human HepG2, HeLa, U251, HOS, MG63, U2OS, MB231, and SKBR-3 cells were obtained from the Cell Library of Committee on Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). Cells were cultured at 37 °C, 5% CO~2~ in the Dulbecco's Modified Eagle's medium (DMEM), Minimum Eagle's medium (MEM), or the Roswell Park Memorial Institute (RPMI) medium containing 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin.

Compounds **1**--**8** were dissolved in DMSO and diluted with DMEM medium (containing 1% FBS and 100 U/mL penicillin/streptomycin) for certain concentrations (1.5625 μM, 3.125 μM, 6.25 μM, 12.5 μM, 25 μM, 50 μM, and 100 μM). The concentration of DMSO in the final solutions was no more than 0.1%. Human HepG2, HeLa, U251, HOS, MG63, U2OS, MB231, and SKBR-3 cells were seeded in 96-well micro-titer plates (100 μL, 1 × 10^4^ cells/well). When the cells grew to certain concentrations (70%--80% of the well), the medium was removed and the diluted compounds (200 μL) were added to each well. Blank (only medium) and control (cells with DMEM medium) group were set to calculate the cell viability and Taxol was used as a positive control. After 48 h, the 96-well micro-titer plates were taken out from the incubator and the medium was removed. When using the MTT assay, DMEM medium (200 μL) should be first added into the well and then followed by MTT (20 μL, 5 mg/mL dissolved in PBS). After culturing for 4 h, the 96-well micro-titer plates were taken out from the incubator and the medium was removed and then 150 μL of DMSO was added into the well. The absorbance was measured by a microplate reader (Bio-Rad, America) at 560 nm. When using CCK-8 assay, DMEM medium (100 μL) should be first added into the well and then CCK-8 (Dojindo, Kumamoto, Japan) followed. After culturing for 2.5 h, the 96-well micro-titer plates were taken out from the incubator and the absorbance was measured by a microplate reader at 450 nm. The cell viability = (Lab group − Blank group)/(Control group − Blank group) and the IC~50~ value was calculated by the software GraphPad Prism 7.0 with the cell viability value.

3.7. Immunoregulation Activity {#sec3dot7-molecules-23-01652}
------------------------------

THP-1 cells were obtained from the Harbin medical university and was cultured in RPMI medium. The cell was seeded in 6-well plate (2 mL, 2 × 10^6^ cell/well) and starved for 12 h. Lipopolysaccharide (LPS, Sigma, St. Louis, MI, USA) (2 mg/mL in PBS) was then added in the well to stimulate the cell. One hour later, each compound was dissolved in DMSO at a concentration of 20 μM. It was added in the well and cultivated for 24 h. The cell was then collected. Following the manufacturer's instructions, the Trizol reagent (Invitrogen, Carlsbad, CA, USA) was used to isolate the total RNA of THP-1 cell. The extracted total RNA was dissolved in RNA enzyme-free water and added into a 100 μL reaction mixture for reverse transcription into complementary DNA (cDNA). The extracted RNA solution contained 8 μg, 8 μL of 50 pmol/μL Oligo d(T)18 and the volume was brought up to 46 μL with RNA enzyme-free water, incubated at 70 °C for 5 min, and then 4 °C for 5 min. Afterward, 20 μL of 2.5 μmol/mL dNTP, 20 μL of 5× RT buffer, 8 μL of dTT, 2 μL of RNA inhibitor, and 4 μL of M-MLV were added and the mixture was incubated at 42 °C for 3 h. The 100 μL mixture was stored at −20 °C for qualitative PCR (qPCR). Detected via qPCR, the gene expression levels were identified with a LightCycler^®^ 480 System (Roche, Basel, Switzerland) using the TransStart^®^ Tip Green qPCR SuperMix (TRANSGEN BIOTECH, Beijing, China). The cDNA was added into a 20 μL reaction mixture: 10 μL of 2× TransStart^®^ Tip Green qPCR SuperMix, 2 μL of cDNA Template (100--200 pg), 0.8 μL of primer mixture (10 μM), 0.4 μL of Passive Reference Dye (50×), and 6.8 μL of ddH*~2~*O. The PCR procedure includes a temperature of 94 °C and a time period of 30 s followed by 40 cycles at 94 °C for 5 s, 57 °C for 15 s, and 72 °C for 10 s. The β-actin gene was used a control to quantify other genes. The results were calculated using 2^−ΔΔ*C*t^ where ΔΔ*C*t = (*C*t Target − *C*t β-actin)Lab − (*C*t Target − *C*t β-actin) Control. Primers of the target gene TNF-α, IL-1β, and β-actin were designed by Primer 5.0 software following the published gene sequence in GenBank: TNF-α Forward: CAGCAAGGGACAGCAGAGG, Reverse: AGTATGTGAGAGGAAGAGAACC; IL-1β Forward: TGATGGCTTATTACAGTGGCAATG, Reverse: TGATGGCTTATTACAGTGGCAATG; β-actin Forward: ATCGGCAATGAGCGGTTCC, Reverse: ATCGGCAATGAGCGGTTCC.

4. Conclusions {#sec4-molecules-23-01652}
==============

In this work, two new phenolic derivatives dryofragone (**1**) and dryofracoumarin B (**2**) were isolated from *Dryopteris fragrans* by cytotoxicity-guided tracking. Two coumarin isomers dryofracoumarin B (**2**) and dryofracoumarin A (**3**) were separated by a silicon etherification-desilication procedure. Compounds (**4**) and (**6**) were first reported in this plant. The cytotoxicity and immuno-regulation activity were examined among the eight compounds and the relationship between cytotoxicity and immuno-regulation activity revealed that compounds may activate the LPS signaling to regulate the growth of tumor cells through immuno-regulation. This relation needs further study.
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molecules-23-01652-t001_Table 1

###### 

NMR data for Compound **1** (TMS as the internal standard, *δ* in ppm, *J* in Hz) ^a^.

  No.   *δ* ~H~        *δ* ~C~      No.   *δ* ~H~                   *δ* ~C~
  ----- -------------- ------------ ----- ------------------------- ---------------
  1                    196.32 (C)   8a    2.99 (1H, m)              41.04 (CH~2~)
  2                    75.37 (C)    8b    2.92 (1H, m)              
  3                    176.04 (C)   9     1.69 (2H, m)              18.71 (CH~2~)
  4     5.37 (1H, s)   94.49 (CH)   10    1.01 (3H, t, *J* = 7.4)   14.07 (CH~3~)
  5                    189.34 (C)   11    1.54 (3H, s)              30.20 (CH~3~)
  6                    104.49 (C)   12    3.91 (3H, s)              57.35 (CH~3~)
  7                    203.65 (C)                                   

^a1^H-NMR and ^13^C-NMR data were recorded in CDCl~3~ at 600 MHz and 150 MHz, respectively.

molecules-23-01652-t002_Table 2

###### 

NMR data for compound **2** and **3** (TMS as the internal standard, *δ* in ppm, *J* in Hz) ^a^.

  No.   2                         3                                         
  ----- ------------------------- --------------- ------------------------- ---------------
  1                                                                         
  2                               161.5 (C)                                 161.1 (C)
  3     6.16 (1H, s)              107.8 (CH)      6.22 (1H, s)              109.2 (CH)
  4                               163.0 (C)                                 163.0 (C)
  5     7.17 (1H, s)              120.0 (CH)      7.01 (1H, s)              115.5 (CH)
  6                               121.1 (C)                                 127.5 (C)
  7                               150.0 (C)                                 147.8 (C)
  8                               133.6 (C)                                 136.7 (C)
  9                               112.2 (C)                                 114.5 (C)
  10                              145.5 (C)                                 141.3 (C)
  11    3.25 (1H, m)              28.7 (CH)       3.25 (1H, m)              28.7 (CH)
  12    1.30 (3H, d, *J* = 6.8)   22.1 (CH~3~)    1.31 (3H, d, *J* = 6.8)   21.9 (CH~3~)
  13    1.30 (3H, d, *J* = 6.8)   22.1 (CH~3~)    1.31 (3H, d, *J* = 6.8)   21.9 (CH~3~)
  14    2.31 (3H, s)              15.9 (CH~3~)    2.32 (3H, s)              16.3 (CH~3~)
  15    4.08 (3H, s)              61.9 (OCH~3~)   3.95 (3H, s)              60.5 (OCH~3~)

^a1^H-NMR and ^13^C-NMR data were recorded in CDCl~3~ at 600 MHz and 150 MHz, respectively.

molecules-23-01652-t003_Table 3

###### 

IC~50~ values (μM) of cytotoxicity for eight compounds against nine human cancer cell lines.

  Compound    HepG2          A549           HeLa           U251           HOS            MG63           U2OS           MB231          SKBR-3
  ----------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- --------------
  **1**       \-             45.86 ± 1.64   25.37 ± 2.62   46.13 ± 1.90   \-             \-             \-             \-             \-
  **2**       45.52 ± 3.21   47.70 ± 2.43   15.12 ± 4.01   46.14 ± 2.40   \-             \-             \-             25.59 ± 2.30   \-
  **3**       48.39 ± 2.15   38.01 ± 3.56   \-             \-             \-             \-             \-             38.09 ± 2.40   \-
  **4**       38.13 ± 1.03   37.41 ± 1.24   1.24 ± 0.08    \-             \-             \-             47.56 ± 2.23   41.95 ± 2.35   \-
  **5**       \-             49.74 ± 3.35   \-             \-             \-             \-             \-             \-             \-
  **6**       \-             47.42 ± 2.25   \-             \-             \-                            \-             \-             \-
  **7**       \-             40.03 ± 0.98   \-             \-             \-             \-             \-             \-             
  **8**       18.02 ± 0.89   \-             17.76 ± 3.43   41.21 ± 1.35   43.67 ± 2.52   22.76 ± 2.65   36.36 ± 1.32   39.61 ± 1.50   33.40 ± 1.50
  Taxol ^a^   5.32 ± 0.12    3.46 ± 0.23    0.17 ± 0.02    5.02 ± 0.21    3.71 ± 0.33    5.86 ± 0.24    1.01 ± 0.03    6.23 ± 0.36    3.12 ± 0.25

Note: IC~50~ values represented the means ± SD of six independent experiments and "-" means the IC~50~ value is above 50 μM. ^a^ Taxol was used as a positive control.
